Company Filing History:
6 out of 4,550 
5 out of 13 
Years Active: 2018-2023
Title: Blake Farrow: Innovator in Biochemical Detection
Introduction
Blake Farrow is a notable inventor based in Pasadena, CA (US). He has made significant contributions to the field of biochemical detection, holding a total of 6 patents. His work focuses on developing innovative capture agents that have applications in medical diagnostics and treatment.
Latest Patents
Farrow's latest patents include groundbreaking technologies such as "Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making." This application provides stable peptide-based Botulinum neurotoxin (BoNT) serotype A capture agents, which are essential for detection and diagnosis, as well as treatment of various diseases and disorders. Additionally, he has developed "IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making." This patent outlines stable peptide-based IL-17F and IL-17A capture agents, which serve as effective detection agents.
Career Highlights
Throughout his career, Blake Farrow has worked with prestigious organizations, including the California Institute of Technology and Indi Molecular, Inc. His innovative research has positioned him as a leader in the field of biochemical detection.
Collaborations
Farrow has collaborated with notable individuals in his field, including James R. Heath and Heather Dawn Agnew. These partnerships have further enhanced his research and development efforts.
Conclusion
Blake Farrow's contributions to the field of biochemical detection through his patents and collaborations highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new diagnostic and therapeutic methods.